Buy Geron Stock | GERN Stock Price & Latest News | Public
GERN

Geron

$0.00 (0.00%)Today

    About GERN

    Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartere...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.03
    -0.05
    -0.08
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.07

    Actual EPS
    Q4 2020

    Stats

    Market Cap$555,74M
    Volume38,48k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$2.40
    1 Year Low$0.75
    Open$1.80
    High$1.81
    Low$1.77

    Buy any stock with any amount of money.

    Download the App
    Download the app